Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI

This study has been completed.

Study NCT00048711 Information provided by BioMarin Pharmaceutical

First Received: November 6, 2002 Last Updated: August 24, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2006
Estimated Primary Completion Date:	No date given